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Two novel angucyclinone-type antibiotics, simocyclinones D4 and D8, were detected in the mycelium extract of Streptomyces antibioticus Tii 6040 by HFLC-diode-array and HPLCelectrospray-mass-spectrometry screening. The compoundsshowantibiotic activities against Gram-positive bacteria and cytostatic effects on various tumor cell lines.
In the course of our search for novel microbial secondary metabolites using HPLC-DAD-MS screening, we investigated streptomycetes strain Tu 6040 which was isolated from a soil sample collected in Iguagu, Argentina.
Humic acid-vitamin agar2) was used for the isolation. The culture nitrate, a 10-fold concentrated ethyl acetate extract thereof, and a methanol extract of the myceliumwere analyzed by gradient reversed-phase HPLCcoupled with a multi-wavelength diode array monitoring system (HPLC-DAD). The UV-visible spectra of the resulting peaks were pp.779 -787 compared with those of 580 reference compounds, mostly antibiotics, stored in our HPLC-UV-Vis-database3).
Compounds presumed novel after the comparison were further analyzed by HPLC-ESI-MS to establish their molecular mass.
The HPLC-DAD analysis of mycelium extract of strain Tii 6040 revealed two compounds (retention time: 10.4 and 10.7 minutes) that have UV-visible spectral maxima at 366 nm and 365nm, respectively (Fig. 1 ). They were found to be similar to a group of reference compounds stored in 
Fermentation and Isolation
Batch fermentations of Streptomyces antibioticus Tii 6040 were carried out in a 20-litre fermenter using a complex medium that consisted of mannitol 2% and soybean meal 2% (pH 7.5). Production of 1 and 2 started at about 25 hours and reached a maximumafter 70 hours with a concentration of 30 and 26mg/litre, respectively, in the mycelium. The beginning of production was correlated with the depletion of the carbon source at the end of the growth phase. The time course of a representative fermentation is shown in Fig. 3 . The simocyclinones were isolated from the mycelium by extraction with MeOH. The extract was concentrated, extracted at pH 4 with ethyl acetate, and subjected to a LiChroprep Diol column to separate 1 from 2 with CH2C12-MeOHgradient elution. Finally, pure simocyclinones were obtained after preparative reversed-phase HPLC using Nucleosil-100 C-18 material and 0.01% trifluoroacetic acid-acetonitrile gradient elution, resulting in yellow powders after concentration to dryness.
781
Characterization and Physico-chemical Properties 1 and 2 in the mycelium extract were characterized as polyene-type antibiotics by means of our HPLC-UV-Vis database. The molecular masses were determined by HPLC-ESI-MS as 897 and 931, respectively The novelty of the compounds was confirmed during the investigations of structure elucidation. The physico-chemical properties of 1 and 2 are summerized in Table 3 , and structures are shown in Fig. 2 . In addition to these two major compounds further metabolites belonging to the simocyclinone group were also detected in the mycelium and culture filtrate extracts.
The production of these compounds is dependent on fermentation conditions, especially on the medium composition1\ HPLC-MS data and structure elucidation suggested, that these compoundsare precursors of 1 and 2.
Biological Properties The antimicrobial spectra of 1 and 2 were determined by an agar plate diffusion assay (Table 4) , and the minimal inhibition concentration by the broth dilution method O mannitol; à" phosphate; X pH; å biomass A simocyclinone D4 (1); V simocyclinone D8 (2).
antibioticus. It is deposited in the culture collection of our institute.
The standard strains for testing the biological activity spectrum were obtained from DSMZ, ATCCand the stock collection of our laboratory. Fermentation S. antibioticus Tii 6040 was cultivated in a 20-litre fermenter (type b20, Giovanola) using a production mediumconsisted ofmannitol 2% and soybean meal 2% in tap water (pH 7.5, adjusted with 5 MNaOH). The fermenter was inoculated with 5 vol-% of shaking cultures, grown for 48 hours in 500-ml Erlenmeyer flasks with one buffle on a rotary shaker at 120 rpm at 27°C in the same medium. The fermentation was carried out for 96 hours at 27°C with an aeration rate of0.5 v/v/m and an agitation of 1000 rpm.
The production of 1 and 2 was measured by reversedphase HPLC. Mannitol was determined by a HPLCmethod described by Plaga et alP\ Phosphate was determined as described by Cooper14).
Isolation Hyphlo Super-eel (2%) was added to the fermentation broth which was separated by multiple sheet filtration into culture filtrate and mycelium. For the isolation of 1 and 2, the myceliumcake was extracted three times with MeOH. After concentration in vacuo, the aqueous residue was adjusted to pH 4 (1 m HC1) and extracted four times with ethyl acetate. After concentration of the organic extract to dryness, it was dissolved in CH2C12 and applied to a diolmodified silica gel column (LiChroprep Diol, 40-63 jim, Merck; 460X26mm).
1 and 2 were separated by linear Table 4 . Antimicrobial spectrum of simocyclinones D4 (1) and D8 (2) Table 6 . Activities (/xmol/litre) of simocyclinones D4 (1) and D8 (2) 
HPLC-DAD-Analysis
The chromatographic system consisted of a HP 1090M
liquid chromatograph equipped with a built-in diode-array detector and HP 79994B workstation (Hewlett-Packard).
Multiple wavelength monitoring was performed at 210, 230, 260, 280, 310, 360 and 435nm. The spectrum range was from 200 to 600 nm with a 2-nm step and a sampling interval of 640 mseconds.
For analysing the mycelium, a lOml-sample of the fermentation broth was centrifuged (10minutes at 13,000 g). The mycelium cake was extracted twice with MeOH, concentrated to dryness and dissolved in 1 ml MeOH. Ten jul of the samples were injected onto a HPLC column (125X4.6mm), fitted with a guard-column (20X4.6mm) which was packed with 5-jiim Nucleosil-100 C-18 (Grom). The samples were analysed by linear gradient elution using 0.1% phosphoric acid as solvent A and acetonitrile as solvent B at a flow rate of 2ml/minute. The gradient was from 0% to 100% solvent B in 15minutes with a 1-minute hold at 100% B, followed by a 5-minute post-time at initial conditions.
HPLC-ESI-MS-Analysis
The system consisted of an ABI 140A HPLCgradient pump (Applied Biosystems) and an API III Taga 6000 E mass spectrometer equipped with a nebulizer-assisted electrospray source (Sciex). The HPLCcolumn eluate was split by a T and introduced into the ion source at a constant flow rate of 40 /il/minute. 4^1 of the samples were injected onto an HPLCcolumn (100X2mm) packed with 3-jum Nucleosil-120 C-18 (Grom). Samples were separated by linear gradient elution. Solvent A was 0.01% trifluoroacetic acid and solvent B was acetonitrile. The gradient was from 0% to 100%solvent B in 60 minutes at a flow rate of200 //1/minute.
Biological Assays An agar plate diffusion assay was used to determine the antimicrobial spectrum of the simocyclinones. Ten ji\ of the samples were applied to filter disks (6 mmdiameter). The test plates were incubated for 24-48 hours at a temperature that permitted an optimal growth of the microorganisms.
A broth dilution method was used to determine the minimal inhibition concentrations of the simocyclinones. The antibiotics were dissolved in DMSOwith final DMSO concentrations in the cultures not to exceed 5%. The bacteria were grown in a mediumconsisted of nutrient broth 0.8% and NaCl 0.5% prepared in tap water. Streptomycetes cultures were grown in malt extract 1%, glucose 0.4% and yeast extract 0.4% in tap water (pH 7.3).
Bacterial cells and spores at 106cells/ml were used as inocula and growth inhibition was evaluated after incubation for 24 and 96hours at 27°C and 37°C, The antitumor activity of 1 and 2 was tested according to NCI guidelines15) with human cell lines from gastric adenocarcinoma (HMO 2), mammacarcinoma (MCF 7) and hepatocellular carcinoma (HEP G2). Cells were grown in 96-well microtiterplates in RPMI 1640 with 10% fetal calf serum in a humidified atmosphere of 5%CO2in air.
After 24hours of incubation 1 and 2 (Q.l~50//mol/litre) were added to the cells. Stock solutions were prepared in DMSO. After 48hour incubation period the cells were fixed, and cell protein was assayed with sulforhodamine B.
